![](/img/cover-not-exists.png)
Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
Bart C.J.M. Fauser, Paul DevroeyVolume:
83
Year:
2005
Language:
english
DOI:
10.1016/j.fertnstert.2005.02.011
File:
PDF, 84 KB
english, 2005